Skip to content
22decisions home

Research brief · HLS-11

From Pilot to Production: Why Healthcare AI Stalls, and How to Scale It

In editorial reviewPlanned publish date: 3 December 2026
Theme
Value and cost
For
CIO, Chief AI Officer
The decision
When do pilots become production?

Summary

When do pilots become production? We map how healthcare and life sciences decision units approach this choice: who decides, who can veto, what AI leaders are doing differently, and what it means for the technology partners they buy from.

The short answer

In healthcare and life sciences, the decision to scale an AI pilot into production is led by the chief AI officer, but the CFO and the CISO can stop it. In healthcare and life sciences, clinical safety, validation, and privacy reviews add stages that pilots in other industries do not face. A typical large healthcare and life sciences organisation involves around 11.1 executives in AI decisions.

Key questions

  • Why do AI pilots stall before production in healthcare and life sciences?
  • Who decides when a pilot scales, and who can stop it?
  • What do organisations that scale AI do differently?
  • How can partners help pilots reach production?

What the full report covers

  • Who is involved in this decision, who decides, and who can say no
  • How AI leaders approach it differently from laggards
  • What technology leaders should do next
  • What it means for the technology and services partners they buy from

Full report: 8 to 10 pages, PDF.

Evidence basis

  • Calibrated model
  • Cited

How we label evidence is explained in our methodology.

Frequently asked questions

Who decides how to scale an AI pilot into production in healthcare and life sciences?
In our decision-rights model, the chief AI officer decides, with input from the wider decision unit (Calibrated model).
Who can veto it?
The CFO and the CISO can approve or block the decision (Calibrated model).
How much are healthcare and life sciences companies hiring for AI?
AI roles make up 1.2% of current job postings at large US healthcare and life sciences companies, with 69 senior AI roles and 7 AI-governance roles (Measured, October 2026).

Get it first

This brief is planned for 3 December 2026. Request early access and we'll send it to you as soon as it is ready.

The same decision in other industries

More from Healthcare & Life Sciences

Get our research in your inbox

One considered briefing a month on how organisations decide on, buy and adopt AI. Unsubscribe at any time.